TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?

Pierre-Jean Lamy; William Jacot

doi:10.1634/theoncologist.2011-0430

Retour

TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?

Article de revue

Avec comité de lecture

TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?

Pierre-Jean Lamy et William Jacot

The oncologist (Dayton, Ohio), Vol.17(12), pp.e60-e61

12/2012

DOI: https://doi.org/10.1634/theoncologist.2011-0430

PMID: 22821647

Résumé

Letter to the Editor

Confusion between topoisomerase IIα gene amplification and topoisomerase mRNA overexpression is proposed as possibly leading to misinerpretation in a study by Glynn et al. published in an earlier issue of The Oncologist.

Indicateurs

1 Consultations de la notice

Détails

Titre: TOP2A Amplification in Breast Cancer in the Absence of That of HER-2: Myth or Reality?
Créateurs - sans rôle: Pierre-Jean Lamy - Laboratoire de Biologie Spécialisée et d'Oncogénétique and
William Jacot - Département d'Oncologie Médicale, CRLC Val d'Aurelle-Paul Lamarque, Montpellier, France
Détails de publication: The oncologist (Dayton, Ohio), Vol.17(12), pp.e60-e61
Éditeur: AlphaMed Press
Identifiants: 99140169009311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article